CXCR7 Agonist TC14012 Improves Angiogenic Function of Endothelial Progenitor Cells via Activating Akt/eNOS Pathway and Promotes Ischemic Angiogenesis in Diabetic Limb Ischemia

Kai Wang(Shanghai Children's Medical Center), Yi Tan(Nanyang Technological University)

Cardiovascular Drugs and Therapy

April 26, 2022

10.1007/s10557-022-07337-9

Cited by 11

Related Papers

Diabetic Downregulation of Nrf2 Activity via ERK Contributes to Oxidative Stress–Induced Insulin Resistance in Cardiac Cells In Vitro and In Vivo

|Diabetes|2011|394

Sitagliptin‐mediated preservation of endothelial progenitor cell function <i>via</i> augmenting autophagy enhances ischaemic angiogenesis in diabetes

|Journal of Cellular and Molecular Medicine|2017|63

A novel CXCR4 antagonist derived from human SDF-1β enhances angiogenesis in ischaemic mice

|Cardiovascular Research|2009|55

Alterations of <scp>SIRT1</scp>/<scp>SIRT3</scp> subcellular distribution in aging undermine cardiometabolic homeostasis during ischemia and reperfusion

|Aging Cell|2023|27

CXCR7 agonist TC14012 improves angiogenic function of endothelial progenitor cells via activating Akt/eNOS pathway and promotes ischemic angiogenesis in diabetic limb ischemia

|Research Square|2022|1